Both lidocaine and ropivacaine further inhibit cancer cell migration and invasion by blocking TNF-α-induced Src phosphorylation and reducing ICAM-1 expression, which are essential for cellular adhesion in lung cancer cells [195,196]. Here, TNF is linked to cancer.